Latest filing published 06 Apr 2011 for Ocera Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
H.I.G. Ventures - Tranzyme, LLC: trading record in brief
H.I.G. Ventures - Tranzyme, LLC is a declared insider of Ocera Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 2 filings, all for trades on 6 April 2011.
Purchases make up the whole of the open-market record (1 purchase, €2.3M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The latest filing, published on 6 April 2011, reports a transaction in Ocera Therapeutics, Inc. The last purchase on record was published on 6 April 2011, which is 5,696 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to H.I.G. Ventures - Tranzyme, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,189,791 sharesCommon StockSEC:0001104659-11-018940:0
- 812,500 shares@ US$4.00Common StockSEC:0001104659-11-018940:1Canonical exit: 5 Jul 2011 (T+90)
2 of 2 declarations
